Hickman Lisa Caronia, Kotlyar Alexander, Shue Shirley, Falcone Tommaso
Department of Obstetrics and Gynecology, Cleveland Clinic Foundation, Cleveland, Ohio.
Department of Obstetrics and Gynecology, Cleveland Clinic Foundation, Cleveland, Ohio.
J Minim Invasive Gynecol. 2016 May-Jun;23(4):497-504. doi: 10.1016/j.jmig.2016.01.026. Epub 2016 Mar 9.
Uterine leiomyomas are the most common benign gynecologic tumor. They are also a significant cause of morbidity, necessitating treatments ranging from hormonal suppression to surgical intervention. Myomectomy, the removal of these highly vascular tumors, offers significant quality of life and fertility-sparing benefit for patients affected by uterine leiomyomas but with a risk of substantial intraoperative blood loss. This risk of hemorrhage leads not only an increased transfusion rate but also he need for hysterectomy and other potential operative complications. Numerous medical and surgical techniques have been developed to minimize potentially significant blood loss during abdominal, laparoscopic, and robotic-assisted myomectomies. Combined with judicious preoperative assessment, these techniques substantially enhance patient safety during a myomectomy and outcomes during recovery.
子宫平滑肌瘤是最常见的妇科良性肿瘤。它们也是发病的重要原因，需要从激素抑制到手术干预等多种治疗方法。肌瘤切除术，即切除这些血管丰富的肿瘤，为受子宫平滑肌瘤影响的患者带来了显著的生活质量改善和保留生育能力的益处，但存在术中大量失血的风险。这种出血风险不仅导致输血率增加，还需要进行子宫切除术及其他潜在的手术并发症。已经开发了许多医学和外科技术，以尽量减少腹部、腹腔镜和机器人辅助肌瘤切除术中可能出现的大量失血。结合审慎的术前评估，这些技术可在肌瘤切除术中大幅提高患者安全性，并改善恢复期间的预后。
